M3554 targets GD2 on the cell surface, is internalized, and releases an exatecan-based topoisomerase I inhibitor that causes TOP1-mediated DNA damage and cell death. Killing depends on GD2 targeting; DNA topoisomerase I is the intracellular payload target, not the directly targeted antigen.